Literature DB >> 28480214

Intra-luminal focused ultrasound for augmentation of gastrointestinal drug delivery.

Ezekiel Maloney1, Joo Ha Hwang2.   

Abstract

Entities:  

Year:  2017        PMID： 28480214      PMCID： PMC5401665          DOI： 10.21037/atm.2017.03.42

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  7 in total

1.  Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer.

Authors:  Tong Li; Yak-Nam Wang; Tatiana D Khokhlova; Samantha D'Andrea; Frank Starr; Hong Chen; Jeannine S McCune; Linda J Risler; Afshin Mashadi-Hossein; Sunil R Hingorani; Amy Chang; Joo Ha Hwang
Journal:  Cancer Res       Date:  2015-07-27       Impact factor: 12.701

Review 2.  High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives.

Authors:  Michele Diana; Luigi Schiraldi; Yu-Yin Liu; Riccardo Memeo; Didier Mutter; Patrick Pessaux; Jacques Marescaux
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

Review 3.  Drug and gene delivery across the blood-brain barrier with focused ultrasound.

Authors:  Kelsie F Timbie; Brian P Mead; Richard J Price
Journal:  J Control Release       Date:  2015-09-08       Impact factor: 9.776

4.  Enhancement of Small Molecule Delivery by Pulsed High-Intensity Focused Ultrasound: A Parameter Exploration.

Authors:  Yufeng Zhou; Yak-Nam Wang; Navid Farr; Jasmine Zia; Hong Chen; Bong Min Ko; Tatiana Khokhlova; Tong Li; Joo Ha Hwang
Journal:  Ultrasound Med Biol       Date:  2016-01-21       Impact factor: 2.998

5.  Ultrasound-mediated gastrointestinal drug delivery.

Authors:  Carl M Schoellhammer; Avi Schroeder; Ruby Maa; Gregory Yves Lauwers; Albert Swiston; Michael Zervas; Ross Barman; Angela M DiCiccio; William R Brugge; Daniel G Anderson; Daniel Blankschtein; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

Review 6.  Current and emerging drugs for the treatment of inflammatory bowel disease.

Authors:  John K Triantafillidis; Emmanuel Merikas; Filippos Georgopoulos
Journal:  Drug Des Devel Ther       Date:  2011-04-06       Impact factor: 4.162

7.  Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis.

Authors:  Prashant Kedia; Russell D Cohen
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.